Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic Biomarkers of Meningioma: A Focused Review
Jacob Pawloski, Hassan Fadel, Yi‐Wen Huang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10222-10222
Open Access | Times Cited: 22

Showing 22 citing articles:

M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-β Signaling Pathway
Xiaohong Fu, Jianping Li, Xueying Li, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 22
CDKN2A/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data
Johannes Wach, Alim Emre Basaran, Felix Arlt, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Predictors of early and late postoperative seizures in meningioma patients: a systematic review and meta-analysis
Alina Ghazou, Ahmed Yassin, Ahmed Aljabali, et al.
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access | Times Cited: 5
Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells
Hailiang Tang, Feng Xu, Dan Sun, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 2
Open Access
Liquid biopsy evaluation of circulating tumor DNA, miRNAs, and cytokines in meningioma patients
Veronica Aran, Renan Lyra Miranda, Manoela Heringer, et al.
Frontiers in Neurology (2024) Vol. 14
Open Access | Times Cited: 4
Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers
Maria Roxana Biricioiu, Mirela Sârbu, Raluca Ică, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1335-1335
Open Access | Times Cited: 4
Current knowledge on spinal meningiomas: a systematic review protocol
Victor Gabriel El-Hajj, Jenny Pettersson Segerlind, Gustav Burström, et al.
BMJ Open (2022) Vol. 12, Iss. 6, pp. e061614-e061614
Open Access | Times Cited: 15
Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review
Atsushi Okano, Satoru Miyawaki, Yu Teranishi, et al.
Neurologia medico-chirurgica (2022) Vol. 62, Iss. 8, pp. 347-360
Open Access | Times Cited: 9
Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
Reem Halabi, Fatima Dakroub, Mohammad Z. Haider, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5339-5339
Open Access | Times Cited: 5
Hsa_circ_0004872 mitigates proliferation, metastasis and immune escape of meningioma cells by suppressing PD-L1
K. Chen, Zhengming Huang, Changsheng Liu, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 5, pp. 895-907
Open Access | Times Cited: 1
Surgery alone versus surgery plus adjuvant radiotherapy for WHO grade 2 meningioma: meta-analysis of reconstructed time-to-event data
Gabriel Verly, Lucas Bresciani, Thiffany Delfino, et al.
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access | Times Cited: 1
Molecular determinants of outcomes in meningiomas
John Lynes, Gabriel Flores-Milán, Sebastian Rubino, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Clinical Management of Supratentorial Non-Skull Base Meningiomas
Adefisayo Adekanmbi, Mark W. Youngblood, Constantine L. Karras, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5887-5887
Open Access | Times Cited: 7
Unveiling a Biomarker Signature of Meningioma: the Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
Reem Halabi, Fatima Dakroub, Mohammad Z. Haider, et al.
(2023)
Open Access | Times Cited: 2
Differences in merlin and p53 expression as a predisposing factor in orbital meningioma
Raudatul Janah, Lantip Rujito, Daniel Joko Wahyono
Journal of Neurosciences in Rural Practice (2024), pp. 1-7
Open Access
Management of Recurrent Skull Base Meningiomas
Sachin Govind, Khizar R. Nandoliya, Rushmin Khazanchi, et al.
(2024), pp. 215-224
Closed Access
Brain cancer and World Health Organization
Moirangthem Gelson Singh, Sanjay Saxena, Sarthak Padhi, et al.
Elsevier eBooks (2024), pp. 57-83
Closed Access
Meningeal Tumors (General Principles)
Usama AlDallal, Leen Rikan Azzam, Sami Al-Horani, et al.
(2024), pp. 89-107
Closed Access
ADAM12 Silencing Mediated by FOXC2 Represses Meningioma Progression Through Inactivating the JAK1/STAT3/VEGFA Pathway
H Zhang, Bing Yang
Biochemical Genetics (2024)
Closed Access
Protein expression of CD44 in patients with meningioma tumors: association with clinicopathological parameters and survival
Trupti Trivedi, Neha Bhalala, Kirti Dialani, et al.
Journal of the Egyptian National Cancer Institute (2024) Vol. 36, Iss. 1
Open Access
Unveiling a Biomarker Signature of Meningioma: the Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
Reem Halabi, Fatima Dakroub, Mohammad Z. Haider, et al.
(2023)
Open Access | Times Cited: 1
Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers
Maria Roxana Biricioiu, Mirela Sârbu, Raluca Ică, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top